openPR Logo
Press release

Hypertensive Emergency Medications Market to Undertake Strapping Growth During 2018 to 2028

10-17-2018 01:29 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Hypertensive Emergency Medications Market to Undertake

Hypertensive emergency is the sudden elevation of blood pressure with signs of damage to the target organs such as the brain, kidneys and cardiovascular system. Hypertensive emergency medications are the immediate treatment required to reduce elevated blood pressure to prevent further damage to the organs. In a hypertensive emergency, acute organ damage has already occurred, and it requires blood reduction within one hour to prevent further damage to organs. Patients need effective medications to lower the elevated blood pressure and to protect target organ function. Neurologic end-organ damage due to hypertensive emergencies includes cerebral infarction, subarachnoid haemorrhage and others. Cardiovascular end-organ damage includes myocardial infarction, ventricular dysfunction, aortic dissection and others. With the advent of hypertensive emergency medications, the incidence of hypertension emergencies has decreased. Patients need rapidly acting medication administered intravenously to lower the elevated blood pressure.

The traditional drug for treating hypertensive emergency is sodium nitroprusside. The amount of dosage and the drug choice varies according to the type of disorder. Patients with acute myocardial infarction need to be treated with intravenous esmolol. There are several drugs to choose from for the management of hypertensive emergencies, which include nitroglycerin, labetalol, fenoldopam, nicardipine and clevidipine, among others. According to NCBI, total hypertensive emergencies have increased by 16.2% per year from 2006 to 2013.

Hypertensive Emergency Medications Market: Drivers and Restraints

The growing prevalence of hypertension is expected to be a major factor driving the hypertensive emergency medications market over the forecast period. The rise in geriatric population is also boosting the market of hypertensive emergency medications. Unhealthy lifestyle is also contributing to the growing prevalence of various cardiovascular system disorders, which is also boosting the hypertensive emergency medications market.

However, various adverse effects associated with the usage of drugs is hampering the growth of the hypertensive emergency medications market. Lack of awareness among individuals is also expected to restrain the growth of the hypertensive emergency medications market during the forecast period.

You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1298 

Hypertensive Emergency Medications Market: Segmentation

The global hypertensive emergency medications market can be segmented on the basis of indication, route of administration, distribution channel and geography.

Based on indications, the global hypertensive emergency medications market is segmented as:

Cardiopulmonary
Central Nervous System
Renal
Others
Based on the route of administration, the global hypertensive emergency medications market is segmented as:

Intravenous
Oral
Transdermal
Sublingual
Others
Based on the distribution channel, the global hypertensive emergency medications market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Hypertensive Emergency Medications Market: Overview

The global market for Hypertensive Emergency Medications is expected to grow at a significant rate over the forecast period. Effective management of hypertensive emergency requires careful considerations of aetiology and the indicated treatment. Nitroprusside has been one of the most commonly used hypertensive emergency medications because of its rapid onset and effectiveness. However, its usage has been decreasing owing to awareness about its level of toxicity. Nowadays, it is used in combination with other drugs to decrease the toxicity level. Several clinical studies have to be performed to improve the treatment and lower the adverse effects of hypertensive emergency medications. The intravenous route of drug administration is the most common form of administration for several drugs because of its rapid effect.

Visit For TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1298 

Hypertensive Emergency Medications Market: Regional Outlook

Geographically, the global hypertensive emergency medications market has been segmented into North America, Latin America, Europe, Asia-Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global hypertensive emergency medications market owing to the high prevalence diseases and rise in geriatric population. In addition, a large number of key players offering hypertensive emergency medications are present in this region. Europe is expected to hold the second-largest share in the global hypertensive emergency medications market throughout the forecast period due to the availability of better healthcare facilities. The hypertensive emergency medications market in Asia Pacific is expected to grow at a significant CAGR due to rise in elderly population. However, Middle East and Africa is expected to register slower growth due to lack of awareness among individuals as well as poor healthcare facilities.

Hypertensive Emergency Medications Market: Key Players

The global market for hypertensive emergency medications is highly fragmented. Some of the key players operating in the global hypertensive emergency medications market are Alvogen, Inc.; Baxter Laboratories Pty Ltd.; NuCare Pharmaceuticals, Inc.; Pfizer Inc.; Exela Pharma Sciences LLC; Nexus Pharmaceuticals, Inc.; Novartis International AG and F. Hoffmann-La Roche AG.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, Rest of LatAm)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe and Rest of Europe)
CIS & Russia
Asia Pacific Excluding Japan (China, India, S.Korea, ASEAN countries, Rest of APEJ)
Japan
Middle East and Africa (GCC, S. Africa, Turkey, Iran, Israel, Rest of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/1298/hypertensive-emergency-medications-market 

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypertensive Emergency Medications Market to Undertake Strapping Growth During 2018 to 2028 here

News-ID: 1310085 • Views:

More Releases from Fact.MR

System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: Fact.MR Report
System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: …
The global system integration market is estimated to have a valuation of US$ 401.8 billion in 2024. Projections put the CAGR of the market for the 2024 to 2034 period at a remarkable 18.7%. The market's growth over the forecast period is set to inflate significantly, reaching a projected value of US$ 2,236.6 billion by 2034. The System Integration Industry sales study offers a comprehensive analysis on diverse features including production
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fact.MR Report
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fac …
Bromelain market size is pegged at US$ 27.3 million for 2024. Worldwide demand for bromelain is predicted to increase at a robust CAGR of 7.5% and reach a market value of US$ 56.2 million by the end of 2034. The Bromelain Industry sales study offers a comprehensive analysis on diverse features including production capacities, Bromelain demand, product developments, sales revenue generation and Bromelain market outlook across the globe. market research report by
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of 2034: Fact.MR Report
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of …
The global writing instrument market size is calculated at US$ 14.28 billion for 2024 and is projected to reach US$ 20.54 billion by 2034-end. Worldwide demand for writing instruments is projected to expand at a CAGR of 3.7% from 2024 to 2034. The Writing Instrument Industry sales study offers a comprehensive analysis on diverse features including production capacities, Writing Instrument demand, product developments, sales revenue generation and Writing Instrument market outlook
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach US$ 19.9 Billion by 2033
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach U …
The worldwide data mining and visualization market in the life sciences sector is projected to exceed $8.3 billion by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.1%, reaching $19.9 billion by 2033. In 2022, revenue from data mining and visualization in the life sciences amounted for 7% of the total data analytics market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗢𝗳 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=459 Using data mining and visualization

All 5 Releases


More Releases for Hypertensive

Anti-Hypertensive Drugs Market Size & Growth Analysis Report, 2020-2026
The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased
Anti-Hypertensive Drugs Market Size, Share and Forecast 2020-2026
The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased
Anti-Hypertensive Drugs Market Growth, Size, Share and Forecast 2020-2026
The global anti-hypertension drugs market is estimated to grow at a CAGR of over 4% during the forecast period. Hypertension is a common condition among patients with diabetes. Hence, the adoption of anti-hypertensive is high among the diabetic population for the treatment of hypertension. Hence, the increased diabetic population coupled with the adoption of anti-hypertensive drugs is anticipated to drive the anti-hypertensive drug market industry significantly. Additionally, Angiotensin-converting enzyme (ACE)
Global Hypertensive Heart Disease Market Research and Forecast, 2018-2023
Global hypertensive heart disease market, size, share, market intelligence, company profiles, market trends, strategy, research and analysis report by diagnosis (coronary angiography, chest x-ray, echo and electrocardiogram) forecast 2018-2023 “Increasing prevalence of heart disease is augmenting the growth of hypertensive heart disease market” According to OMR analysis, the global hypertensive heart diseases market is estimated to grow with a significant CAGR during the forecast period, 2018-2023. The rising prevalence of hypertensive
What's Behind the Rise of Anti-Hypertensive Drugs Market | Health
The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults. Thus the market is expected to grow at a CAGR of 2.73% from 2016 to 2022. Anti-hypertensive drugs are
Future of Anti-Hypertensive Drugs Market 2025: Sanofi, Lupin, AstraZeneca
HTF MI published a new industry research that focuses on Anti-Hypertensive Drugs market and delivers in-depth market analysis and future prospects of Global Anti-Hypertensive Drugs market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is